COUGHLIN CHRISTOPHER J
Insider CIK 1110750 · CNC Director · DNB Director · PBH Director · COV Director · DPRX Director · ACT Director · KRTX Director · FRX Director · HOLX Director · ALXN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CNC CENTENE CORP | A Award | 2026-09-30 | 2026-09-30 | 583 | — | $0 | 19,294 | SEC↗ |
| CNC CENTENE CORP | A Award | 2026-09-30 | 2026-09-30 | 583 | — | $0 | 19,294 | SEC↗ |
| CNC CENTENE CORP | A Award | 2026-06-30 | 2026-07-01 | 562 | — | $0 | 18,711 | SEC↗ |
| CNC CENTENE CORP | A Award | 2026-05-12 | 2026-05-13 | 3,992 | — | $0 | 18,149 | SEC↗ |
| CNC CENTENE CORP | A Award | 2026-03-31 | 2026-03-31 | 1,140 | — | $0 | 14,157 | SEC↗ |
| CNC CENTENE CORP | A Award | 2025-12-31 | 2026-01-05 | 729 | — | $0 | 13,017 | SEC↗ |
| CNC CENTENE CORP | A Award | 2025-09-30 | 2025-10-01 | 852 | — | $0 | 12,288 | SEC↗ |
| CNC CENTENE CORP | A Award | 2025-06-30 | 2025-07-02 | 556 | — | $0 | 11,436 | SEC↗ |
| CNC CENTENE CORP | A Award | 2025-05-13 | 2025-05-14 | 3,579 | — | $0 | 10,880 | SEC↗ |
| CNC CENTENE CORP | A Award | 2025-03-31 | 2025-04-02 | 500 | — | $0 | 7,301 | SEC↗ |
| CNC CENTENE CORP | A Award | 2024-12-31 | 2025-01-03 | 497 | — | $0 | 6,801 | SEC↗ |
| CNC CENTENE CORP | P Buy | 2024-12-16 | 2024-12-17 | 10,000 | $59.44 | $594.4K | 36,358 | SEC↗ |
| CNC CENTENE CORP | A Award | 2024-09-30 | 2024-10-02 | 402 | — | $0 | 26,358 | SEC↗ |
| CNC CENTENE CORP | A Award | 2024-06-30 | 2024-07-02 | 452 | — | $0 | 25,956 | SEC↗ |
| CNC CENTENE CORP | A Award | 2024-05-14 | 2024-05-16 | 2,916 | — | $0 | 25,504 | SEC↗ |
| CNC CENTENE CORP | S Sale | 2024-05-14 | 2024-05-24 | 878 | $76.75 | $67.4K | 0 | SEC↗ |
| CNC CENTENE CORP | A Award | 2024-03-31 | 2024-04-02 | 389 | — | $0 | 22,588 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | D To issuer deriv | 2024-03-18 | 2024-03-18 | 8,500 | $201.99 | $1.72M | 0 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | D To issuer deriv | 2024-03-18 | 2024-03-18 | 25,000 | $243.35 | $6.08M | 0 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | D To issuer deriv | 2024-03-18 | 2024-03-18 | 5,000 | $227.04 | $1.14M | 0 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | D To issuer deriv | 2024-03-18 | 2024-03-18 | 976 | $136.81 | $133.5K | 0 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | D To issuer deriv | 2024-03-18 | 2024-03-18 | 1,904 | $92.30 | $175.7K | 0 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | D To issuer | 2024-03-18 | 2024-03-18 | 990 | $330.00 | $326.7K | 0 | SEC↗ |
| CNC CENTENE CORP | A Award | 2023-12-31 | 2024-01-03 | 503 | — | $0 | 22,199 | SEC↗ |
| CNC CENTENE CORP | A Award | 2023-09-30 | 2023-10-03 | 545 | — | $0 | 21,697 | SEC↗ |
| CNC CENTENE CORP | A Award | 2023-06-30 | 2023-07-05 | 544 | — | $0 | 21,152 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | A Award deriv | 2023-06-20 | 2023-06-22 | 1,904 | — | $0 | 1,904 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | A Award | 2023-06-20 | 2023-06-22 | 990 | — | $0 | 990 | SEC↗ |
| CNC CENTENE CORP | A Award | 2023-05-10 | 2023-05-12 | 2,947 | — | $0 | 20,608 | SEC↗ |
| CNC CENTENE CORP | A Award | 2023-03-31 | 2023-04-04 | 511 | — | $0 | 17,661 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | A Award deriv | 2023-01-03 | 2023-01-05 | 321 | $110.41 | $35.4K | 321 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | A Award deriv | 2023-01-03 | 2023-01-05 | 407 | $110.57 | $45.0K | 407 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | A Award deriv | 2023-01-03 | 2023-01-05 | 67 | $111.94 | $7.5K | 67 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | A Award deriv | 2023-01-03 | 2023-01-05 | 181 | $110.50 | $20.0K | 181 | SEC↗ |
| CNC CENTENE CORP | A Award | 2022-12-31 | 2023-01-04 | 444 | — | $0 | 17,151 | SEC↗ |
| CNC CENTENE CORP | A Award | 2022-09-30 | 2022-10-04 | 406 | — | $0 | 16,707 | SEC↗ |
| PBH Prestige Consumer Healthca | A Award | 2022-08-02 | 2022-08-03 | 2,495 | — | $0 | 13,218 | SEC↗ |
| CNC CENTENE CORP | A Award | 2022-06-30 | 2022-07-05 | 436 | — | $0 | 16,301 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | A Award deriv | 2022-06-15 | 2022-06-16 | 5,000 | — | $0 | 5,000 | SEC↗ |
| CNC CENTENE CORP | P Buy | 2022-04-29 | 2022-05-03 | 12,000 | $81.37 | $976.4K | 15,865 | SEC↗ |
| CNC CENTENE CORP | A Award | 2022-04-26 | 2022-04-28 | 2,323 | — | $0 | 3,865 | SEC↗ |
| CNC CENTENE CORP | A Award | 2022-03-31 | 2022-04-04 | 442 | $82.02 | $36.3K | 1,542 | SEC↗ |
| CNC CENTENE CORP | A Award deriv | 2022-02-07 | 2022-02-09 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CNC CENTENE CORP | A Award | 2022-02-07 | 2022-02-09 | 1,100 | — | $0 | 1,100 | SEC↗ |
| PBH Prestige Consumer Healthca | A Award | 2021-08-03 | 2021-08-05 | 2,808 | — | $0 | 10,723 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | D To issuer deriv | 2021-07-21 | 2021-07-23 | 2,343 | $155.01 | $363.2K | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | D To issuer deriv | 2021-07-21 | 2021-07-23 | 2,294 | $138.86 | $318.5K | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | D To issuer deriv | 2021-07-21 | 2021-07-23 | 2,706 | $167.97 | $454.5K | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | D To issuer | 2021-07-21 | 2021-07-23 | 42,347 | — | $0 | 0 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | A Award deriv | 2021-06-16 | 2021-06-23 | 8,500 | — | $0 | 8,500 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | A Award | 2021-05-20 | 2021-05-24 | 729 | — | $0 | 42,347 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | A Award | 2021-05-20 | 2021-05-24 | 1,962 | — | $0 | 41,618 | SEC↗ |
| PBH Prestige Consumer Healthca | A Award | 2020-08-04 | 2020-08-06 | 3,732 | — | $0 | 7,915 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | A Award | 2020-05-14 | 2020-05-18 | 3,468 | — | $0 | 36,882 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | A Award | 2020-05-14 | 2020-05-18 | 2,774 | — | $0 | 39,656 | SEC↗ |
| AGN Allergan plc | D To issuer deriv | 2020-05-08 | 2020-05-11 | 9,446 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | D To issuer deriv | 2020-05-08 | 2020-05-11 | 2,790 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | D To issuer deriv | 2020-05-08 | 2020-05-11 | 3,691 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | D To issuer | 2020-05-08 | 2020-05-11 | 9,538 | — | $0 | 16,542 | SEC↗ |
| AGN Allergan plc | D To issuer | 2020-05-08 | 2020-05-11 | 16,532 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | D To issuer | 2020-05-08 | 2020-05-11 | 471 | — | $0 | 26,080 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2020-05-01 | 2020-05-04 | 991 | $189.74 | $188.0K | 16,542 | SEC↗ |
| KRTX Karuna Therapeutics, Inc. | A Award deriv | 2020-04-24 | 2020-04-28 | 25,000 | — | $0 | 25,000 | SEC↗ |
| PBH Prestige Consumer Healthca | A Award | 2019-07-30 | 2019-08-01 | 4,183 | — | $0 | 4,183 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | A Award | 2019-05-15 | 2019-05-17 | 2,181 | — | $0 | 33,414 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | A Award | 2019-05-15 | 2019-05-17 | 2,726 | — | $0 | 31,233 | SEC↗ |
| AGN Allergan plc | A Award | 2019-05-02 | 2019-05-02 | 2,064 | $145.33 | $300.0K | 17,080 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2019-04-30 | 2019-05-02 | 953 | $147.00 | $140.1K | 15,016 | SEC↗ |
| AGN Allergan plc | P Buy | 2018-09-06 | 2018-09-07 | 27 | $190.57 | $5.1K | 8,463 | SEC↗ |
| AGN Allergan plc | P Buy | 2018-09-06 | 2018-09-07 | 705 | $190.56 | $134.3K | 8,436 | SEC↗ |
| AGN Allergan plc | P Buy | 2018-09-06 | 2018-09-07 | 1,300 | $190.55 | $247.7K | 7,731 | SEC↗ |
| AGN Allergan plc | P Buy | 2018-09-06 | 2018-09-07 | 300 | $190.63 | $57.2K | 16,431 | SEC↗ |
| AGN Allergan plc | P Buy | 2018-09-06 | 2018-09-07 | 517 | $190.64 | $98.6K | 16,131 | SEC↗ |
| AGN Allergan plc | P Buy | 2018-09-06 | 2018-09-07 | 4,889 | $190.68 | $932.2K | 15,614 | SEC↗ |
| AGN Allergan plc | P Buy | 2018-09-06 | 2018-09-07 | 222 | $190.67 | $42.3K | 10,725 | SEC↗ |
| AGN Allergan plc | P Buy | 2018-09-06 | 2018-09-07 | 816 | $190.66 | $155.6K | 10,503 | SEC↗ |
| AGN Allergan plc | P Buy | 2018-09-06 | 2018-09-07 | 400 | $190.60 | $76.2K | 9,319 | SEC↗ |
| AGN Allergan plc | P Buy | 2018-09-06 | 2018-09-07 | 68 | $190.62 | $13.0K | 9,587 | SEC↗ |
| AGN Allergan plc | P Buy | 2018-09-06 | 2018-09-07 | 200 | $190.61 | $38.1K | 9,519 | SEC↗ |
| AGN Allergan plc | P Buy | 2018-09-06 | 2018-09-07 | 100 | $190.58 | $19.1K | 8,563 | SEC↗ |
| AGN Allergan plc | P Buy | 2018-09-06 | 2018-09-07 | 356 | $190.59 | $67.9K | 8,919 | SEC↗ |
| AGN Allergan plc | P Buy | 2018-09-06 | 2018-09-07 | 100 | $190.65 | $19.1K | 9,687 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2018-05-09 | 2018-05-11 | 2,174 | — | $0 | 28,507 | SEC↗ |
| AGN Allergan plc | A Award | 2018-05-02 | 2018-05-04 | 1,985 | $151.07 | $299.9K | 6,431 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | P Buy | 2018-04-30 | 2018-05-02 | 10,000 | $120.79 | $1.21M | 26,333 | SEC↗ |
| AGN Allergan plc | G Gift | 2018-02-28 | 2018-05-04 | 10,000 | — | $0 | 4,446 | SEC↗ |
| AGN Allergan plc | P Buy | 2017-12-05 | 2017-12-05 | 10,000 | $163.30 | $1.63M | 14,446 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2017-12-05 | 2017-12-05 | 10,000 | $112.75 | $1.13M | 16,333 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | P Buy | 2017-06-15 | 2017-06-16 | 2,000 | $117.10 | $234.2K | 6,333 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2017-05-10 | 2017-05-12 | 2,030 | — | $0 | 4,333 | SEC↗ |
| AGN Allergan plc | A Award | 2017-05-04 | 2017-05-05 | 1,223 | $245.25 | $299.9K | 4,446 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2017-05-03 | 2017-05-05 | 668 | $243.76 | $162.8K | 3,223 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award deriv | 2017-03-10 | 2017-03-13 | 175 | $40.29 | $7.1K | 38,317 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award | 2017-03-10 | 2017-03-13 | 75 | $107.81 | $8.0K | 16,536 | SEC↗ |
| HOLX HOLOGIC INC | A Award deriv | 2017-03-08 | 2017-03-09 | 6,816 | — | $0 | 6,816 | SEC↗ |
| HOLX HOLOGIC INC | M Exercise deriv | 2017-03-08 | 2017-03-09 | 2,427 | — | $0 | 0 | SEC↗ |
| HOLX HOLOGIC INC | A Award | 2017-03-08 | 2017-03-09 | 2,206 | — | $0 | 7,633 | SEC↗ |
| HOLX HOLOGIC INC | M Exercise | 2017-03-08 | 2017-03-09 | 2,427 | — | $0 | 5,427 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award deriv | 2017-01-31 | 2017-02-02 | 728 | $45.73 | $33.3K | 38,142 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | M Exercise deriv | 2017-01-26 | 2017-01-27 | 2,086 | — | $0 | 0 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | M Exercise | 2017-01-26 | 2017-01-27 | 2,086 | $88.04 | $183.7K | 18,547 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award deriv | 2016-12-09 | 2016-12-13 | 144 | $46.00 | $6.6K | 37,414 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award | 2016-12-09 | 2016-12-13 | 63 | $122.96 | $7.7K | 16,461 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award deriv | 2016-09-09 | 2016-09-13 | 133 | $49.52 | $6.6K | 37,270 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award | 2016-09-09 | 2016-09-13 | 57 | $134.56 | $7.7K | 16,399 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2016-08-15 | 2016-08-17 | 100 | $254.05 | $25.4K | 3,891 | SEC↗ |
| AGN Allergan plc | A Award | 2016-08-08 | 2016-08-09 | 201 | $248.31 | $49.9K | 3,991 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award deriv | 2016-06-30 | 2016-07-05 | 2,300 | $45.44 | $104.5K | 37,137 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award deriv | 2016-06-10 | 2016-06-14 | 131 | $46.88 | $6.2K | 34,838 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award | 2016-06-10 | 2016-06-14 | 61 | $126.04 | $7.6K | 16,342 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award deriv | 2016-05-11 | 2016-05-13 | 2,294 | $138.86 | $318.5K | 2,294 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2016-05-11 | 2016-05-13 | 835 | — | $0 | 2,303 | SEC↗ |
| AGN Allergan plc | A Award | 2016-05-05 | 2016-05-09 | 1,188 | $210.34 | $249.9K | 3,790 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award | 2016-05-04 | 2016-05-06 | 1,087 | — | $0 | 16,281 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award deriv | 2016-03-11 | 2016-03-15 | 164 | $37.41 | $6.1K | 34,706 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award | 2016-03-11 | 2016-03-15 | 72 | $98.98 | $7.1K | 15,194 | SEC↗ |
| HOLX HOLOGIC INC | A Award deriv | 2016-03-02 | 2016-03-04 | 7,402 | — | $0 | 7,402 | SEC↗ |
| HOLX HOLOGIC INC | A Award deriv | 2016-03-02 | 2016-03-04 | 2,427 | — | $0 | 2,427 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award deriv | 2016-01-29 | 2016-02-02 | 2,837 | $36.84 | $104.5K | 34,542 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award deriv | 2015-12-11 | 2015-12-15 | 140 | $38.55 | $5.4K | 31,705 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award | 2015-12-11 | 2015-12-15 | 65 | $103.68 | $6.8K | 15,122 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | M Exercise deriv | 2015-11-06 | 2015-11-10 | 2,330 | — | $0 | 0 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | M Exercise | 2015-11-06 | 2015-11-10 | 2,330 | $71.28 | $166.1K | 17,387 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | S Sale | 2015-11-06 | 2015-11-10 | 2,330 | $112.50 | $262.1K | 15,057 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award deriv | 2015-09-11 | 2015-09-15 | 136 | $39.26 | $5.4K | 31,566 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award | 2015-09-11 | 2015-09-15 | 64 | $104.56 | $6.7K | 15,057 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2015-08-23 | 2015-08-25 | 124 | $298.57 | $37.0K | 2,602 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2015-08-15 | 2015-08-18 | 100 | $314.50 | $31.4K | 2,726 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award deriv | 2015-06-30 | 2015-07-01 | 2,296 | $45.52 | $104.5K | 31,429 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award deriv | 2015-06-12 | 2015-06-16 | 102 | $48.14 | $4.9K | 29,134 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award | 2015-06-12 | 2015-06-16 | 52 | $129.73 | $6.7K | 14,993 | SEC↗ |
| ACT Actavis plc | A Award | 2015-06-05 | 2015-06-08 | 826 | $302.30 | $249.7K | 2,826 | SEC↗ |
| AGN Allergan plc | A Award | 2015-06-05 | 2015-06-30 | 826 | $302.30 | $249.7K | 2,826 | SEC↗ |
| ACT Actavis plc | F Tax w/h | 2015-06-04 | 2015-06-08 | 334 | $303.38 | $101.3K | 2,000 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2015-06-04 | 2015-06-30 | 334 | $303.38 | $101.3K | 2,000 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award deriv | 2015-05-06 | 2015-05-08 | 2,343 | $155.01 | $363.2K | 2,343 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award | 2015-05-06 | 2015-05-08 | 954 | — | $0 | 14,941 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2015-05-06 | 2015-05-08 | 700 | — | $0 | 1,468 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award deriv | 2015-03-11 | 2015-03-13 | 104 | $47.20 | $4.9K | 29,031 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award | 2015-03-11 | 2015-03-13 | 49 | $127.21 | $6.2K | 13,987 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award deriv | 2015-01-30 | 2015-02-03 | 2,431 | $42.99 | $104.5K | 28,927 | SEC↗ |
| COV Covidien plc | D To issuer deriv | 2015-01-26 | 2015-01-28 | 55,004 | — | $0 | 0 | SEC↗ |
| COV Covidien plc | D To issuer deriv | 2015-01-26 | 2015-01-28 | 14,109 | — | $0 | 0 | SEC↗ |
| COV Covidien plc | D To issuer deriv | 2015-01-26 | 2015-01-28 | 55,004 | — | $0 | 0 | SEC↗ |
| COV Covidien plc | D To issuer deriv | 2015-01-26 | 2015-01-28 | 10,521 | — | $0 | 0 | SEC↗ |
| COV Covidien plc | D To issuer | 2015-01-26 | 2015-01-28 | 49,475 | — | $0 | 0 | SEC↗ |
| COV Covidien plc | D To issuer | 2015-01-26 | 2015-01-28 | 7,970 | — | $0 | 0 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award deriv | 2014-12-12 | 2014-12-16 | 100 | $42.50 | $4.3K | 26,496 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award | 2014-12-12 | 2014-12-16 | 52 | $114.86 | $5.9K | 13,938 | SEC↗ |
| ACT Actavis plc | A Award | 2014-10-30 | 2014-11-03 | 694 | $243.21 | $168.8K | 18,261 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award deriv | 2014-09-12 | 2014-09-16 | 98 | $43.67 | $4.3K | 26,396 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award | 2014-09-12 | 2014-09-16 | 50 | $117.05 | $5.9K | 13,887 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award deriv | 2014-07-22 | 2014-07-24 | 2,706 | $167.97 | $454.5K | 2,706 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2014-07-22 | 2014-07-24 | 768 | — | $0 | 768 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award deriv | 2014-07-01 | 2014-07-02 | 2,501 | $41.79 | $104.5K | 26,298 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer deriv | 2014-07-01 | 2014-07-03 | 5,909 | — | $0 | 0 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer deriv | 2014-07-01 | 2014-07-03 | 7,815 | — | $0 | 0 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer deriv | 2014-07-01 | 2014-07-03 | 20,000 | — | $0 | 0 | SEC↗ |
| ACT Actavis plc | A Award deriv | 2014-07-01 | 2014-07-03 | 3,691 | — | $0 | 3,691 | SEC↗ |
| ACT Actavis plc | A Award deriv | 2014-07-01 | 2014-07-03 | 2,790 | — | $0 | 2,790 | SEC↗ |
| ACT Actavis plc | A Award deriv | 2014-07-01 | 2014-07-03 | 9,446 | — | $0 | 9,446 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer | 2014-07-01 | 2014-07-03 | 2,406 | — | $0 | 0 | SEC↗ |
| FRX Forest Laboratories, LLC | D To issuer | 2014-07-01 | 2014-07-03 | 1,527 | — | $0 | 0 | SEC↗ |
| ACT Actavis plc | A Award | 2014-07-01 | 2014-07-03 | 1,640 | — | $0 | 1,640 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award deriv | 2014-06-13 | 2014-06-17 | 99 | $38.88 | $3.8K | 23,798 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award | 2014-06-13 | 2014-06-17 | 57 | $103.94 | $5.9K | 13,836 | SEC↗ |
| COV Covidien plc | A Award | 2014-05-21 | 2014-05-23 | 420 | — | $0 | 49,446 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award | 2014-05-07 | 2014-05-09 | 1,141 | — | $0 | 13,780 | SEC↗ |
| COV Covidien plc | F Tax w/h | 2014-03-19 | 2014-03-21 | 1,046 | $70.68 | $73.9K | 49,016 | SEC↗ |
| COV Covidien plc | A Award | 2014-03-19 | 2014-03-21 | 2,264 | — | $0 | 50,062 | SEC↗ |
| DPRX Dipexium Pharmaceuticals, | P Buy | 2014-03-18 | 2014-03-20 | 2,083 | $12.00 | $25.0K | 109,309 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award deriv | 2014-03-12 | 2014-03-14 | 104 | $36.77 | $3.8K | 23,699 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award | 2014-03-12 | 2014-03-14 | 54 | $98.08 | $5.3K | 12,639 | SEC↗ |
| COV Covidien plc | A Award | 2014-02-20 | 2014-02-24 | 12 | $71.28 | $855 | 47,798 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award deriv | 2014-01-31 | 2014-02-04 | 2,544 | $41.08 | $104.5K | 23,595 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award deriv | 2013-12-13 | 2013-12-17 | 72 | $42.99 | $3.1K | 21,051 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award | 2013-12-13 | 2013-12-17 | 42 | $116.06 | $4.8K | 12,584 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | M Exercise deriv | 2013-11-12 | 2013-11-14 | 2,746 | — | $0 | 0 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | M Exercise deriv | 2013-11-12 | 2013-11-14 | 1,573 | — | $0 | 0 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | M Exercise | 2013-11-12 | 2013-11-14 | 1,573 | $59.86 | $94.2K | 14,116 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | S Sale | 2013-11-12 | 2013-11-14 | 4,319 | $110.75 | $478.3K | 12,543 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | M Exercise | 2013-11-12 | 2013-11-14 | 2,746 | $60.54 | $166.2K | 16,862 | SEC↗ |
| COV Covidien plc | A Award | 2013-11-05 | 2013-11-07 | 13 | $64.33 | $836 | 47,786 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award deriv | 2013-10-22 | 2013-10-24 | 1,374 | $40.02 | $55.0K | 20,979 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award deriv | 2013-09-18 | 2013-09-20 | 72 | $40.32 | $2.9K | 19,605 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award | 2013-09-18 | 2013-09-20 | 45 | $106.96 | $4.8K | 12,543 | SEC↗ |
| FRX FOREST LABORATORIES INC | A Award deriv | 2013-08-15 | 2013-08-16 | 5,909 | — | $0 | 5,909 | SEC↗ |
| FRX FOREST LABORATORIES INC | A Award | 2013-08-15 | 2013-08-16 | 1,761 | — | $0 | 3,933 | SEC↗ |
| COV Covidien plc | A Award | 2013-08-15 | 2013-08-16 | 11 | $61.85 | $680 | 47,773 | SEC↗ |
| COV Covidien plc | A Award | 2013-07-17 | 2013-07-19 | 248 | — | $0 | 47,762 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award deriv | 2013-07-01 | 2013-07-03 | 1,647 | $36.74 | $60.5K | 19,534 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award deriv | 2013-06-13 | 2013-06-17 | 70 | $37.25 | $2.6K | 17,887 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award | 2013-06-13 | 2013-06-17 | 49 | $98.79 | $4.8K | 12,497 | SEC↗ |
| COV Covidien plc | A Award | 2013-05-03 | 2013-05-07 | 8 | $64.35 | $515 | 47,302 | SEC↗ |
| COV Covidien plc | A Award | 2013-03-20 | 2013-03-22 | 2,214 | — | $0 | 48,346 | SEC↗ |
| COV Covidien plc | F Tax w/h | 2013-03-20 | 2013-03-22 | 1,052 | $65.50 | $68.9K | 47,294 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award deriv | 2013-03-14 | 2013-03-18 | 86 | $30.51 | $2.6K | 17,816 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award | 2013-03-14 | 2013-03-18 | 59 | $81.23 | $4.8K | 12,449 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award | 2013-02-19 | 2013-02-21 | 1,453 | $82.56 | $120.0K | 12,390 | SEC↗ |
| COV Covidien plc | M Exercise deriv | 2013-02-05 | 2013-02-06 | 12,000 | — | $0 | 0 | SEC↗ |
| COV Covidien plc | M Exercise deriv | 2013-02-05 | 2013-02-06 | 12,000 | — | $0 | 0 | SEC↗ |
| COV Covidien plc | M Exercise deriv | 2013-02-05 | 2013-02-06 | 12,000 | — | $0 | 0 | SEC↗ |
| COV Covidien plc | M Exercise | 2013-02-05 | 2013-02-06 | 12,000 | $45.45 | $545.4K | 24,000 | SEC↗ |
| COV Covidien plc | S Sale | 2013-02-05 | 2013-02-06 | 36,000 | $62.05 | $2.23M | 0 | SEC↗ |
| COV Covidien plc | M Exercise | 2013-02-05 | 2013-02-06 | 12,000 | $36.99 | $443.9K | 36,000 | SEC↗ |
| COV Covidien plc | M Exercise | 2013-02-05 | 2013-02-06 | 12,000 | $45.66 | $547.9K | 12,000 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award deriv | 2013-02-01 | 2013-02-05 | 1,950 | $31.03 | $60.5K | 17,730 | SEC↗ |
| COV Covidien plc | A Award | 2012-12-27 | 2012-12-28 | 12 | $57.35 | $688 | 46,132 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award deriv | 2012-12-13 | 2012-12-17 | 73 | $30.26 | $2.2K | 15,781 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award | 2012-12-13 | 2012-12-17 | 49 | $80.90 | $4.0K | 10,937 | SEC↗ |
| COV Covidien plc | A Award | 2012-11-05 | 2012-11-07 | 13 | $55.65 | $723 | 46,120 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award deriv | 2012-09-18 | 2012-09-20 | 71 | $31.27 | $2.2K | 15,708 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award | 2012-09-18 | 2012-09-20 | 47 | $83.39 | $4.0K | 10,888 | SEC↗ |
| FRX FOREST LABORATORIES INC | A Award deriv | 2012-08-23 | 2012-08-27 | 7,815 | — | $0 | 7,815 | SEC↗ |
| FRX FOREST LABORATORIES INC | A Award | 2012-08-23 | 2012-08-27 | 2,172 | — | $0 | 2,172 | SEC↗ |
| COV Covidien plc | A Award | 2012-08-16 | 2012-08-20 | 10 | $57.59 | $576 | 46,107 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award deriv | 2012-07-02 | 2012-07-05 | 1,836 | $26.96 | $49.5K | 15,229 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award deriv | 2012-06-13 | 2012-06-15 | 74 | $25.56 | $1.9K | 13,393 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award | 2012-06-13 | 2012-06-15 | 58 | $67.32 | $3.9K | 10,841 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award deriv | 2012-05-09 | 2012-05-11 | 134 | $23.85 | $3.2K | 13,320 | SEC↗ |
| COV Covidien plc | A Award | 2012-05-07 | 2012-05-09 | 11 | $54.25 | $597 | 46,097 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award deriv | 2012-03-14 | 2012-03-16 | 50 | $32.18 | $1.6K | 13,185 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award | 2012-03-14 | 2012-03-16 | 46 | $85.91 | $3.9K | 10,782 | SEC↗ |
| COV Covidien plc | F Tax w/h | 2012-03-13 | 2012-03-14 | 1,033 | $53.89 | $55.7K | 46,086 | SEC↗ |
| COV Covidien plc | A Award | 2012-03-13 | 2012-03-14 | 2,691 | — | $0 | 47,119 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award deriv | 2012-03-01 | 2012-03-05 | 1,590 | $31.14 | $49.5K | 13,135 | SEC↗ |
| COV Covidien plc | A Award | 2012-02-22 | 2012-02-24 | 11 | $52.45 | $577 | 44,428 | SEC↗ |
| DNB DUN & BRADSTREET CORP/NW | A Award | 2012-02-13 | 2012-02-15 | 1,517 | $79.11 | $120.0K | 10,737 | SEC↗ |